Corcept Therapeutics CORT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent.
The official record: Corcept Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corcept Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corcept Therapeutics's operating lease ROU assets?
- Corcept Therapeutics (CORT) reported operating lease ROU assets of 8.3% in Q1 2026.
- How has Corcept Therapeutics's operating lease ROU assets changed year-over-year?
- Corcept Therapeutics's operating lease ROU assets decreased by 2.4% year-over-year, from 8.5% to 8.3%.
- What is the long-term trend for Corcept Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Corcept Therapeutics's operating lease ROU assets has grown at a 12.8% compound annual growth rate (CAGR), from 250,900,000% to 458,300,000%.
- What does operating lease ROU assets mean?
- The value of the right to use leased property or equipment over the duration of the lease agreement.
- How do you interpret operating lease ROU assets?
- Increases generally reflect expansion of facilities or office space, while decreases indicate downsizing or lease expirations.
- How does operating lease ROU assets compare across companies?
- Standardized under ASC 842, making it comparable across companies with significant real estate footprints.